"A Shot in the Dark"

Related

• 

  “Real World” U.S. Outcomes of Anti-VEGF Therapy in Neovascular AMD: Risk of Vision Loss is Greatest in Patients with Better Baseline Visual Acuity

  Thomas A. Ciulla, MD, MBA, FASRS

  Annual Meeting Talks

  2016

• 

  Vision Loss in a Patient With Primary Pulmonary Hypertension and Long-Term Use of Sildenafil

  Christina Y Weng, MD, MBA, FASRS

  Annual Meeting Talks

  2016

• 

  AMD Neovascular Expert Panel

  Robert L. Avery, MD

  Nizar S Abdelfattah, M.D.

  Nancy M. Holekamp, MD, FASRS

  Peter K. Kaiser, MD FASRS

  Pravin U. Dugel, MD

  Annual Meeting Talks

  2016